Norbert Gattermann

Norbert Gattermann

UNVERIFIED PROFILE

Are you Norbert Gattermann?   Register this Author

Register author
Norbert Gattermann

Norbert Gattermann

Publications by authors named "Norbert Gattermann"

Are you Norbert Gattermann?   Register this Author

100Publications

2135Reads

30Profile Views

Neut-X can be successfully used as diagnostic and prognostic tool in MDS.

Leuk Res 2019 Nov 13;86:106224. Epub 2019 Sep 13.

Universitätsklinikum Düsseldorf, Heinrich-Heine-University, Moorenstr. 5, Düsseldorf, 40225, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2019.106224DOI Listing
November 2019

Molecular genetics in allogeneic blood stem cell transplantation for myelodysplastic syndromes.

Expert Rev Hematol 2019 Oct 25;12(10):821-831. Epub 2019 Jul 25.

Departments of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Medical Faculty, University Hospital Düsseldorf , Düsseldorf , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1645004DOI Listing
October 2019

Novel therapies in low- and high-risk myelodysplastic syndrome.

Expert Rev Hematol 2019 Oct 31;12(10):893-908. Epub 2019 Jul 31.

Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf , Düsseldorf , Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2019.1647778DOI Listing
October 2019

Hematologic improvement with iron chelation therapy in myelodysplastic syndromes: Clinical data, potential mechanisms, and outstanding questions.

Crit Rev Oncol Hematol 2019 Sep 10;141:54-72. Epub 2019 Jun 10.

Dept. of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10408428183031
Publisher Site
http://dx.doi.org/10.1016/j.critrevonc.2019.06.002DOI Listing
September 2019

Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy.

Ann Hematol 2018 Dec 4;97(12):2325-2332. Epub 2018 Aug 4.

Department of Hematology, Oncology and Clinical Immunology, University Hospital, Heinrich Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-018-3466-7DOI Listing
December 2018

Effect of deferasirox + erythropoietin vs erythropoietin on erythroid response in Low/Int-1-risk MDS patients: Results of the phase II KALLISTO trial.

Eur J Haematol 2018 May 19. Epub 2018 May 19.

The First Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, Zhejiang, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.13096DOI Listing
May 2018

Iron overload in myelodysplastic syndromes (MDS).

Int J Hematol 2018 Jan 25;107(1):55-63. Epub 2017 Nov 25.

Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-017-2367-1DOI Listing
January 2018

Cytogenetic clonal evolution in myelodysplastic syndromes is associated with inferior prognosis.

Cancer 2017 Dec 26;123(23):4608-4616. Epub 2017 Jul 26.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Dusseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30917DOI Listing
December 2017

A retrospective study evaluating the impact of infectious complications during azacitidine treatment.

Ann Hematol 2017 Jul 4;96(7):1097-1104. Epub 2017 May 4.

Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Moorenstraße 5, 40225, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-017-3001-2DOI Listing
July 2017

New proposals of the WHO working group (2016) for the diagnosis of myelodysplastic syndromes (MDS): Characteristics of refined MDS types.

Leuk Res 2017 06 27;57:78-84. Epub 2017 Feb 27.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2017.02.008DOI Listing
June 2017

Iron rusting in the mitochondria?

Blood 2016 10;128(15):1907-1908

HEINRICH HEINE UNIVERSITY DÜSSELDORF.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-08-732966DOI Listing
October 2016

Randomized Phase III Study of Lenalidomide Versus Placebo in RBC Transfusion-Dependent Patients With Lower-Risk Non-del(5q) Myelodysplastic Syndromes and Ineligible for or Refractory to Erythropoiesis-Stimulating Agents.

J Clin Oncol 2016 09 27;34(25):2988-96. Epub 2016 Jun 27.

Valeria Santini, University of Florence, Florence, Italy; Antonio Almeida, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal; Aristoteles Giagounidis and Stefanie Gröpper, Marien Hospital Düsseldorf; Norbert Gattermann, Heinrich-Heine-Universität, Düsseldorf; Uwe Platzbecker, Technical University Dresden, Dresden, Germany; Anna Jonasova, Charles University General Hospital, Prague, Czech Republic; Norbert Vey, Centre Régional de Lutte Contre le Cancer, Marseille; Pierre Fenaux, Université Paris, Paris, France; Francis Séguy and Albert Hoenekopp, Celgene International, Boudry, Switzerland; Ghulam J. Mufti, King's College Hospital, London, United Kingdom; Rena Buckstein, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Moshe Mittelman and Ron Ram, Tel Aviv University; Ofer Shpilberg, Assuta Medical Center, Tel Aviv, Israel; Consuelo del Cañizo, Hospital Universitario de Salamanca, Salamanca; Alberto Risueño, Celgene Institute for Translational Research Europe, Seville, Spain; Keiya Ozawa, The University of Tokyo, Tokyo, Japan; Kyle J. MacBeth, Celgene Corporation, San Francisco, CA; and Jianhua Zhong and C.L. Beach, Celgene Corporation, Summit, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.66.0118DOI Listing
September 2016

Causes of death in 2877 patients with myelodysplastic syndromes.

Ann Hematol 2016 May 30;95(6):937-44. Epub 2016 Mar 30.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-016-2649-3DOI Listing
May 2016

γ-Glutamyl Transferase Is an Independent Biomarker of Splanchnic Thrombosis in Patients With Myeloproliferative Neoplasm.

Medicine (Baltimore) 2016 May;95(20):e3355

From the Department of Internal Medicine I (GJ, HLM, PM, JC, LJ, SC, TJ); Department of Medical Clinic III, University of Bonn, Bonn (VM, HA, BP, WD); Department of Hematology, Oncology, Hemostaseology, and SCT, Faculty of Medicine, University Hospital of the RWTH Aachen University, Aachen (KA, BTH, KS); Department of Biometrics, Informatics and Epidemiology, University of Bonn, Bonn (FR); Department for Hematology, University Hospital Essen, Essen (GJ); Department for Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf (GN); Practice for Hematology-Oncology Eppendorf, Hamburg (GE); and Department for Hematology, University Hospital Dresden, Dresden, Germany (PU).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000003355DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902387PMC
May 2016

New insights into transfusion-related iron toxicity: Implications for the oncologist.

Crit Rev Oncol Hematol 2016 Mar 27;99:261-71. Epub 2015 Nov 27.

Heinrich-Heine-Universität, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2015.11.017DOI Listing
March 2016

Cellularity, characteristics of hematopoietic parameters and prognosis in myelodysplastic syndromes.

Eur J Haematol 2015 Sep 15;95(3):181-9. Epub 2015 May 15.

Department of Hematology, Oncology, and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12512DOI Listing
September 2015

In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over time.

Br J Haematol 2015 Sep 11;170(5):687-93. Epub 2015 May 11.

Klinik für Hämatologie Onkologie und Klinische Immunologie, Heinrich-Heine-Universität, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13496DOI Listing
September 2015

Impaired cytotoxicity associated with defective natural killer cell differentiation in myelodysplastic syndromes.

Haematologica 2015 May 14;100(5):643-52. Epub 2015 Feb 14.

Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Düsseldorf, Germany

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2014.118679DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420213PMC
May 2015

Serum hepcidin measured with an improved ELISA correlates with parameters of iron metabolism in patients with myelodysplastic syndrome.

Ann Hematol 2013 Dec 11;92(12):1617-23. Epub 2013 Jul 11.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Moorenstr. 5, 40225, Düsseldorf, Germany,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-013-1839-5DOI Listing
December 2013

The impact of age on the diagnosis and therapy of myelodysplastic syndromes: results from a retrospective multicenter analysis in Germany.

Eur J Haematol 2013 Dec 18;91(6):473-82. Epub 2013 Sep 18.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ejh.12196DOI Listing
December 2013

When is iron overload deleterious, and when and how should iron chelation therapy be administered in myelodysplastic syndromes?

Best Pract Res Clin Haematol 2013 Dec 1;26(4):431-44. Epub 2013 Oct 1.

Klinik für Hämatologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universität, Moorenstr. 5, 40225 Düsseldorf, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.beha.2013.09.009DOI Listing
December 2013

Myelodysplastic syndromes: diagnosis, prognosis, and treatment.

Dtsch Arztebl Int 2013 Nov;110(46):783-90

Department of Haematology, Oncology and Clinical Immunology, Düsseldorf University Hospital.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3238/arztebl.2013.0783DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3855821PMC
November 2013

Validation and proposals for a refinement of the WHO 2008 classification of myelodysplastic syndromes without excess of blasts.

Leuk Res 2013 Jan 31;37(1):64-70. Epub 2012 Oct 31.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2012.09.021DOI Listing
January 2013

Diagnosis and therapy of myelodysplastic syndromes in Germany: a retrospective multicenter analysis.

Onkologie 2012 25;35(6):350-6. Epub 2012 May 25.

Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000338939DOI Listing
November 2012

Pathophysiological and clinical aspects of iron chelation therapy in MDS.

Curr Pharm Des 2012 ;18(22):3222-34

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1381612811209023222DOI Listing
October 2012

SF3B1 and the riddle of the ring sideroblast.

Blood 2012 Oct;120(16):3167-8

Heinrich-Heine-University Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2012-08-447094DOI Listing
October 2012

Improved survival in MDS patients receiving iron chelation therapy - a matched pair analysis of 188 patients from the Düsseldorf MDS registry.

Leuk Res 2012 Aug 6;36(8):1067-70. Epub 2012 May 6.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2012.04.006DOI Listing
August 2012

Anaesthesia in a patient with subarachanoidal haemorrhage and high oxygen affinity haemoglobinopathy (HB york): case report.

BMC Anesthesiol 2012 Aug 8;12:19. Epub 2012 Aug 8.

Department of Anaesthesiology, Heinrich-Heine-University, Moorenstrasse 5, D-40225, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2253-12-19DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3459697PMC
August 2012

Evaluation of dysplasia through detailed cytomorphology in 3156 patients from the Düsseldorf Registry on myelodysplastic syndromes.

Leuk Res 2012 Jun 13;36(6):727-34. Epub 2012 Mar 13.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University of Duesseldorf, Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2012.02.014DOI Listing
June 2012

Incidence and prevalence of myelodysplastic syndromes: data from the Düsseldorf MDS-registry.

Leuk Res 2011 Dec 25;35(12):1591-6. Epub 2011 Jun 25.

Department of Hematology, Oncology and Clinical Immunology, Heinrich Heine University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01452126110027
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2011.06.001DOI Listing
December 2011

Impaired mitochondrial gene transcription in myelodysplastic syndromes and acute myeloid leukemia with myelodysplasia-related changes.

Exp Hematol 2011 Jun 27;39(6):666-675.e1. Epub 2011 Mar 27.

Institut für Pathologie, Kliniken der Stadt Köln gGmbH, Köln, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.exphem.2011.03.007DOI Listing
June 2011

Iron overload in MDS-pathophysiology, diagnosis, and complications.

Ann Hematol 2011 Jan 12;90(1):1-10. Epub 2010 Oct 12.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Mooren Str. 5, 40225, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-010-1091-1DOI Listing
January 2011

Practical use of azacitidine in higher-risk myelodysplastic syndromes: an expert panel opinion.

Leuk Res 2010 Nov 6;34(11):1410-6. Epub 2010 Jul 6.

Hôpital Avicenne, Assistance Publique, Hôpitaux de Paris and Paris 13 University, Bobigny, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2010.05.021DOI Listing
November 2010

How to treat MDS without stem cell transplantation.

Biol Blood Marrow Transplant 2010 Jan 24;16(1 Suppl):S30-6. Epub 2009 Oct 24.

Klinik für Hämatologie, Onkologie u. klinische Immunology Heinrich-Heine-Universität Moorenstr. 5D-40225 Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2009.10.017DOI Listing
January 2010

Imatinib in breast milk.

Ann Hematol 2009 Dec 22;88(12):1265-6. Epub 2009 May 22.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00277-009-0754-2DOI Listing
December 2009

Platelet counts and haemorrhagic diathesis in patients with myelodysplastic syndromes.

Eur J Haematol 2009 Nov 22;83(5):477-82. Epub 2009 Jun 22.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University of Duesseldorf, Moorenstrasse 5, D-40225 Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0609.2009.01299.xDOI Listing
November 2009

Impact on survival of different treatments for myelodysplastic syndromes (MDS).

Leuk Res 2009 Aug 30;33(8):1024-8. Epub 2009 Jan 30.

Department of Haematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2008.12.019DOI Listing
August 2009

Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndrome.

J Clin Oncol 2009 Aug 15;27(24):4002-6. Epub 2009 Jun 15.

Department of Haematological Medicine, King's College London School of Medicine, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.22.6985DOI Listing
August 2009

The treatment of secondary hemochromatosis.

Dtsch Arztebl Int 2009 Jul 24;106(30):499-504, I. Epub 2009 Jul 24.

Klinik für Hämatologie, Onkologie und klinische Immunologie, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3238/arztebl.2009.0499DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2735704PMC
July 2009

The hematopoietic stem cell transplantation comorbidity index is of prognostic relevance for patients with myelodysplastic syndrome.

Haematologica 2009 May 31;94(5):729-32. Epub 2009 Mar 31.

Department of Haematology, Oncology and Clinical Immunology Heinrich-Heine-University, Moorenstrasse 5, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2008.002063DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2675687PMC
May 2009

Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia.

Leuk Res 2009 Feb 18;33(2):232-6. Epub 2008 Jul 18.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Moorenstr. 5, 40225 Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S014521260800279
Publisher Site
http://dx.doi.org/10.1016/j.leukres.2008.06.003DOI Listing
February 2009

Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf study.

Hematol Oncol 2008 Dec;26(4):213-8

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Duesseldorf, Moorenstr. Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hon.860DOI Listing
December 2008

Fatal bleeding due to a heparin-like anticoagulant in a 37-year-old woman suffering from systemic mastocytosis.

Clin Appl Thromb Hemost 2008 Jul 26;14(3):360-4. Epub 2007 Dec 26.

Department of Hemostasis and Transfusion Medicine, Heinrich Heine University Medical Center, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1076029607309173DOI Listing
July 2008

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.

Haematologica 2008 Jul 27;93(7):994-1000. Epub 2008 May 27.

LRF Molecular Haematology Unit, Nuffield Department of Clinical, Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK.

View Article

Download full-text PDF

Source
http://www.haematologica.org/cgi/doi/10.3324/haematol.12603
Publisher Site
http://dx.doi.org/10.3324/haematol.12603DOI Listing
July 2008

Overview of guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.

Int J Hematol 2008 Jul 27;88(1):24-29. Epub 2008 Jun 27.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Moorenstr. 5, 40225, Dusseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12185-008-0118-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2516534PMC
July 2008

Analysis of mitochondrial DNA in 104 patients with myelodysplastic syndromes.

Exp Hematol 2008 May;36(5):577-86

Klinik für Hämatologie, Onkologie und Klinische Immunologie, Heinrich-Heine-Universität, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0301472X080002
Publisher Site
http://dx.doi.org/10.1016/j.exphem.2008.01.004DOI Listing
May 2008

Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload.

Leuk Res 2007 Dec;31 Suppl 3:S10-5

Klinik für Hämatologie, Onkologie und klinische Immunologie, Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0145-2126(07)70461-7DOI Listing
December 2007

Arsenic in the cerebrospinal fluid of a patient receiving arsenic trioxide for relapsed acute promyelocytic leukemia with CNS involvement.

Leuk Res 2007 Nov 9;31(11):1585-7. Epub 2007 Apr 9.

Department of Haematology, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 44, 1011, Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2007.03.007DOI Listing
November 2007

Valproic acid for the treatment of myeloid malignancies.

Cancer 2007 Sep;110(5):943-54

Department of Hematology, Oncology, and Clinical Immunology, Heinrich-Heine-University, Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22891DOI Listing
September 2007

Age-related transcription levels of KU70, MGST1 and BIK in CD34+ hematopoietic stem and progenitor cells.

Mech Ageing Dev 2007 Sep 4;128(9):503-10. Epub 2007 Jul 4.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University of Duesseldorf, 40225 Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.mad.2007.06.008DOI Listing
September 2007

Chronic myelomonocytic leukemia in the light of the WHO proposals.

Haematologica 2007 Jul;92(7):974-7

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.11051DOI Listing
July 2007

Myelodysplastic syndromes in patients younger than age 50.

J Clin Oncol 2006 Dec 6;24(34):5358-65. Epub 2006 Nov 6.

Department of Hematology, Oncology, and Clinical Immunology, and Institute of Human Genetics, Heinrich-Heine-University, Duesseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2006.07.5598DOI Listing
December 2006

Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.

Haematologica 2006 Dec;91(12):1596-604

Department of Hematology, Oncology and Clinical Immunology Heinrich-Heine-University Moorenstr. 5, 40225 Düsseldorf, Germany.

View Article

Download full-text PDF

Source
December 2006

X-linked sideroblastic anemia associated with a novel ALAS2 mutation and unfortunate skewed X-chromosome inactivation patterns.

Blood Cells Mol Dis 2006 Jul-Aug;37(1):40-5. Epub 2006 Jun 2.

Department of Hematology, Oncology, and Clinical Immunology, Heinrich Heine-University Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcmd.2006.04.003DOI Listing
September 2006

Optimized PCR fragments for heteroduplex analysis of the whole human mitochondrial genome with denaturing HPLC.

J Chromatogr B Analyt Technol Biomed Life Sci 2006 Feb 10;831(1-2):236-47. Epub 2006 Jan 10.

Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University, Düsseldorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jchromb.2005.12.024DOI Listing
February 2006